BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9844289)

  • 1. [Compliance and asthma--a delphi survey on therapy compliance by by asthma patients in ambulatory care].
    Graf von der Schulenburg JM; Greiner W
    Gesundheitswesen; 1998 Oct; 60(10):558-62. PubMed ID: 9844289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost of asthma therapy in relation to severity. An empirical study].
    Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
    Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a low-cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample.
    Chatkin JM; Blanco DC; Scaglia N; Wagner MB; Fritscher CC
    J Asthma; 2006 May; 43(4):263-6. PubMed ID: 16809238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma therapy in children. Value of long acting beta-mimetic drugs and anti-leukotrienes].
    Nicolai T
    MMW Fortschr Med; 2000 Jun; 142(23):28-31. PubMed ID: 10900948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The quality of asthma treatment in Denmark. How far are we--and how far are our patients?].
    Ulrik CS; Lange P; Plaschke PP; Backer V; Søes-Petersen U; Harving H
    Ugeskr Laeger; 2008 Jan; 170(4):230-4. PubMed ID: 18282453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
    Navarro RP; Parasuraman B
    Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-inflammatory asthma therapy. Effectiveness depends on compliance].
    MMW Fortschr Med; 2001 Jan; 143(4):46-7. PubMed ID: 11219287
    [No Abstract]   [Full Text] [Related]  

  • 8. Asthma control and compliance in a cohort of adult asthmatics: first survey in Israel.
    Starobin D; Bargutin M; Rosenberg I; Yarmolovsky A; Levi T; Fink G
    Isr Med Assoc J; 2007 May; 9(5):358-60. PubMed ID: 17591372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
    Wang SW; Liu X; Wiener DJ; Sennett C; Bowers BW; Legorreta AP
    Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
    Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
    Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD; Turk F
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a regional intervention to promote asthma guidelines implementation].
    Geraedts M; Selbmann HK; Meisner C
    Gesundheitswesen; 2002 May; 64(5):235-41. PubMed ID: 12007064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch.
    Tamura G; Ohta K
    Respir Med; 2007 Sep; 101(9):1895-902. PubMed ID: 17587559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy participation in ambulatory asthma patients: empirical comparison of compliance rates using different operationalization methods for drug compliance].
    Mühlig S; Bergmann KC; Twesten O; Petermann F
    Pneumologie; 2001 Apr; 55(4):177-89. PubMed ID: 11393046
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment.
    Poluzzi E; Resi D; Zuccheri P; Motola D; De Ponti F; Vaccheri A; Montanaro N
    Eur J Clin Pharmacol; 2002 Apr; 58(1):55-9. PubMed ID: 11956674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapeutical management of bronchial asthma].
    Leont'ev SL; Mikhaĭlov VG; Nevzorova VP; Sadovnikova RV; Shabashov AF; Lugovkina TK; Leshchenko IV; Bel'tiukov EK; Lebedeva MK
    Klin Med (Mosk); 1998; 76(10):39-41. PubMed ID: 9865016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
    Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Asthma therapy and compliance].
    Kurz H
    Wien Med Wochenschr; 1998; 148(14):338-41. PubMed ID: 9816646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.